Skip to main content
1005-2015, 1005-2016, 1005-2014, 1005-2017, 1004-2010, 1004-2013, 1006-2020, 1004-2012, 1006-2026
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_504628,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_504628_Omega-3-Fatty-Acids-for-the-Management-of-Hypertriglyceridemia.jsp,docTitle=Omega-3 Fatty Acids for the Management of Hypertriglyceridemia,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=Hypertriglyceridemia (HTG) and very high triglycerides (VHTG) are becoming increasingly prevalent, likely driven by growing rates of obesity and diabetes mellitus.,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=docosahexaenoic acid, eicosapentaenoic acid, fatty acids, omega-3, hypertriglyceridemia, hypolipidemic agents, lipoproteins, triglycerides,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=08/21/2019 8:08 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=08/21/2019 8:05 PM,xWebsiteSection=professional:1463,dDocName=UCM_504628,dpAction=null,dRevLabel=3,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_504628.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=3,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=504628,dIsPrimary=1,dFileSize=17646,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1899924,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=08/21/2019 8:09 PM,xTrashDeleteLoc=null,dCreateDate=08/21/2019 8:08 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=08/19/2019 9:00 AM,xRobotParameter=,xCommunities=1005-2015, 1005-2016, 1005-2014, 1005-2017, 1004-2010, 1004-2013, 1006-2020, 1004-2012, 1006-2026,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia

Pile-of-capsules-Omega-3-on-white-background_750x500
  • Hypertriglyceridemia (HTG) and very high triglycerides (VHTG) are becoming increasingly prevalent, likely driven by growing rates of obesity and diabetes mellitus.
  • This advisory informs providers about newly approved prescription omega-3 fatty acids (n-3 FA) to treat HTG and VHTG.
  • The advisory summarizes clinical evidence on effects of n-3 FA on plasma concentrations of triglycerides and other lipids and lipoproteins in individuals with elevated triglycerides.

Read the full article in Circulation